Estimated glomerular filtration ratio is a better index than creatinine clearance (Cockcroft–Gault) for predicting the prevalence of atrial fibrillation in the general Japanese population

Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used a...

Full description

Saved in:
Bibliographic Details
Published inHypertension research Vol. 41; no. 6; pp. 451 - 459
Main Authors Yonezawa, Yutaka, Horinaka, Shigeo, Shirakawa, Chiaki, Kogure, Yoshio
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.06.2018
Subjects
Online AccessGet full text
ISSN0916-9636
1348-4214
1348-4214
DOI10.1038/s41440-018-0032-6

Cover

Abstract Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.
AbstractList Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.
Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft-Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39-31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11-4.30), age > 65 years (OR = 2.52, CI 2.14-2.96), hyperlipidemia (OR = 2.51, CI 1.97-3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19-1.58) and hypertension (OR = 1.14, CI 1.11-1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21-3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.
Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr (Cockcroft–Gault) is recommended as a criterion for the reduction of DOAC. In contrast, estimated glomerular filtration rate (eGFR) is usually used as an index of renal function in daily practice. We determined the age- and gender-specific prevalence rates of AF and whether CCr or eGFR was associated with the prevalence of AF. Data from the periodic health examinations of 108,951 subjects were collected. Risk factors for AF were determined based on medical history, physical examinations and blood samples, and AF was diagnosed based on electrocardiography. The prevalence rate of AF was 0.92% (998/108,951). It was four times higher in men than in women and increased with age. Cardiac disease (odds ratio (OR) = 27.07, confidence interval (CI) 23.39–31.37, p = 0.0001), male gender (OR = 3.65, CI 3.11–4.30), age > 65 years (OR = 2.52, CI 2.14–2.96), hyperlipidemia (OR = 2.51, CI 1.97–3.20), BMI > 25 kg/m2 (OR = 1.37, CI 1.19–1.58) and hypertension (OR = 1.14, CI 1.11–1.16) were independently associated with a high risk of AF in the multivariate logistic regression analysis. The odds ratio of having AF was significantly higher in patients with eGFR ≤ 59 (OR = 2.10, CI 1.21–3.86) than in those with eGFR ≥ 90 but was not associated with CCr after adjustments for age, gender, diabetes mellitus and smoking. The significance of this difference disappeared after additional adjustment for hypertension. Cardiac disease, gender, age, hyperlipidemia, obesity, hypertension and renal dysfunction were strong risk factors for AF. The evaluation of renal dysfunction as a morbidity risk factor for AF suggests that eGFR should be used.
Author Horinaka, Shigeo
Shirakawa, Chiaki
Kogure, Yoshio
Yonezawa, Yutaka
Author_xml – sequence: 1
  givenname: Yutaka
  surname: Yonezawa
  fullname: Yonezawa, Yutaka
– sequence: 2
  givenname: Shigeo
  surname: Horinaka
  fullname: Horinaka, Shigeo
– sequence: 3
  givenname: Chiaki
  surname: Shirakawa
  fullname: Shirakawa, Chiaki
– sequence: 4
  givenname: Yoshio
  surname: Kogure
  fullname: Kogure, Yoshio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29559690$$D View this record in MEDLINE/PubMed
BookMark eNp1kktuFDEQhi0URCaBA7BBltiERYNf3W0v0SgEUCQ2sLbc7urBwWM3tjuCHXfgPFyGk-CZTjaRWJWs-v56uP4zdBJiAISeU_KaEi7fZEGFIA2hsiGEs6Z7hDaUC9kIRsUJ2hBFu0Z1vDtFZznfEMJkq-gTdMpU26pOkQ36c5mL25sCI975uIe0eJPw5HxJprgY8DFgl7HBA5QCCbswwg9cvpqAbYKaDi4Ath5MMsECvthG-82mOJW_v35fmcWXV3iKCc8JRmcrvqtiODxvjYeDIk7YlOSMr42H5LxfW7twBHcQINXcRzObALkq47ysyFP0eDI-w7O7eI6-vLv8vH3fXH-6-rB9e91YLlRpjGpZx5Ude86UMCMBCnboacus6STlRClCjJCtZIQrKhSzba96OXDKGGkNP0cXa905xe8L5KL3LluogwaIS9aM0K7lrJNtRV8-QG_ikkKdrlJCSUkF7Sv14o5ahj2Mek71COmnvj9MBfoVqB-Zc4JJW1eOO9fDOK8p0QcL6NUCulpAHyygu6qkD5T3xf-v-QdRgLXw
CitedBy_id crossref_primary_10_1038_s41440_019_0384_6
crossref_primary_10_1681_ASN_2020030301
crossref_primary_10_1016_j_lanwpc_2022_100439
crossref_primary_10_1007_s00059_023_05181_7
crossref_primary_10_1016_j_mce_2020_110984
crossref_primary_10_1007_s40256_022_00560_7
crossref_primary_10_1253_circj_CJ_20_0329
crossref_primary_10_2147_VHRM_S284248
Cites_doi 10.1056/NEJMoa1107039
10.1093/ejechocard/jen117
10.1001/jama.292.20.2471
10.1053/j.ajkd.2010.02.344
10.1016/j.amjcard.2010.06.030
10.1161/01.CIR.101.18.2200
10.1001/jama.285.18.2370
10.1371/journal.pone.0155581
10.1159/000180580
10.1053/j.ajkd.2008.12.034
10.7326/0003-4819-130-6-199903160-00002
10.1056/NEJMoa041031
10.1056/NEJMoa1009638
10.1681/ASN.2013040361
10.1161/HYPERTENSIONAHA.111.179713
10.1371/journal.pone.0079717
10.1016/j.ahj.2009.06.031
10.4070/kcj.2016.46.4.515
10.1177/0091270011409231
10.1056/NEJMoa0905561
10.1056/NEJMoa1007432
10.1253/circj.CJ-11-1134
10.1592/phco.30.8.776
10.1161/01.CIR.96.7.2455
10.1056/NEJMoa1105594
10.1016/S0140-6736(09)61340-4
10.1093/eurheartj/ehs274
10.1093/ndt/gfs607
10.1253/circj.CJ-11-0780
10.1016/j.jacc.2010.02.029
10.1093/eurheartj/eht328
10.1093/ndt/gft006
10.1053/j.ajkd.2010.02.337
10.1016/j.ijcard.2008.06.029
10.1001/jama.1994.03510350050036
10.1371/journal.pone.0143205
10.1161/CIRCULATIONAHA.112.107128
10.1016/j.amjcard.2017.01.005
10.1016/j.amjcard.2008.06.018
10.1161/01.HYP.0000102971.85504.7c
10.1111/j.1532-5415.1985.tb07117.x
ContentType Journal Article
Copyright Copyright Nature Publishing Group Jun 2018
Copyright_xml – notice: Copyright Nature Publishing Group Jun 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1038/s41440-018-0032-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1348-4214
EndPage 459
ExternalDocumentID 29559690
10_1038_s41440_018_0032_6
Genre Journal Article
Comparative Study
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
-Q-
0R~
29I
39C
4.4
406
53G
5GY
70F
7X7
88E
8FI
8FJ
AACDK
AANZL
AASML
AATNV
AAYXX
ABAKF
ABBRH
ABDBE
ABFSG
ABJNI
ABLJU
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACRQY
ACSTC
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HMCUK
HZ~
IWAJR
JSH
JSO
JZLTJ
M1P
NQJWS
O9-
OK1
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TSG
UKHRP
XSB
.55
2WC
ABAWZ
ALIPV
BAWUL
CGR
CUY
CVF
DIK
ECM
EIF
EMB
EMOBN
JSF
KQ8
LGEZI
LOTEE
NADUK
NPM
NXXTH
RJT
RZJ
SV3
TKC
TR2
W2D
X7M
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c349t-a952639cd73294ad0e1ecb7152ca681309900a485820391492c57978b312205a3
IEDL.DBID 7X7
ISSN 0916-9636
1348-4214
IngestDate Fri Sep 05 03:58:02 EDT 2025
Sat Sep 20 14:20:50 EDT 2025
Mon Jul 21 06:08:05 EDT 2025
Thu Apr 24 22:50:24 EDT 2025
Wed Oct 01 04:50:23 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c349t-a952639cd73294ad0e1ecb7152ca681309900a485820391492c57978b312205a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 29559690
PQID 2049881417
PQPubID 2043497
PageCount 9
ParticipantIDs proquest_miscellaneous_2016532685
proquest_journals_2049881417
pubmed_primary_29559690
crossref_citationtrail_10_1038_s41440_018_0032_6
crossref_primary_10_1038_s41440_018_0032_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Tokyo
PublicationTitle Hypertension research
PublicationTitleAlternate Hypertens Res
PublicationYear 2018
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References JB Olesen (32_CR5) 2012; 367
I Grundvold (32_CR26) 2012; 59
S Matsuo (32_CR37) 2009; 53
SJ Connolly (32_CR17) 2009; 361
TC Dowling (32_CR8) 2010; 30
AS Levey (32_CR36) 1999; 130
M Horio (32_CR45) 2010; 56
BM Psaty (32_CR2) 1997; 96
MR Patel (32_CR18) 2011; 365
P Delanaye (32_CR34) 2013; 28
S Matsuo (32_CR14) 2009; 53
Y Ohyama (32_CR39) 2013; 8
SJ Connolly (32_CR43) 2011; 364
S Harder (32_CR6) 2012; 52
M Abe (32_CR12) 2017; 119
AS Go (32_CR1) 2001; 285
UB Tedrow (32_CR24) 2010; 55
Y Iguchi (32_CR40) 2008; 102
MJ Sarnak (32_CR4) 2003; 42
S Apostolakis (32_CR10) 2013; 34
SH Hohnloser (32_CR9) 2012; 33
H Watanabe (32_CR29) 2011; 75
RL Schmidt (32_CR32) 2015; 10
EJ Benjamin (32_CR25) 1994; 271
MK Son (32_CR27) 2016; 46
W Shang (32_CR3) 2016; 11
TJ Wang (32_CR21) 2004; 292
Y Iguchi (32_CR30) 2010; 106
DW Cockcroft (32_CR16) 1976; 16
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (32_CR15) 2013; 3
Z Harel (32_CR7) 2014; 25
CB Granger (32_CR19) 2011; 365
AS Levey (32_CR44) 2010; 55
CA Garza (32_CR22) 2008; 9
CB Granger (32_CR42) 2011; 365
SI Hallan (32_CR35) 2013; 28
HW Smith (32_CR38) 1951
H Watanabe (32_CR41) 2009; 158
H Inoue (32_CR20) 2009; 137
P Verdecchia (32_CR28) 2009; 374
JP Piccini (32_CR11) 2013; 127
AS Go (32_CR13) 2004; 351
S Suzuki (32_CR31) 2011; 75
F Bode (32_CR23) 2000; 101
RD Lindeman (32_CR33) 1985; 33
References_xml – volume: 365
  start-page: 981
  year: 2011
  ident: 32_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1107039
– volume: 9
  start-page: 587
  year: 2008
  ident: 32_CR22
  publication-title: Eur J Echocardiogr
  doi: 10.1093/ejechocard/jen117
– volume: 292
  start-page: 2471
  year: 2004
  ident: 32_CR21
  publication-title: JAMA
  doi: 10.1001/jama.292.20.2471
– start-page: 1
  volume-title: The kidney: structure and functional in health and disease
  year: 1951
  ident: 32_CR38
– volume: 56
  start-page: 32
  year: 2010
  ident: 32_CR45
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2010.02.344
– volume: 106
  start-page: 1129
  year: 2010
  ident: 32_CR30
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2010.06.030
– volume: 101
  start-page: 2200
  year: 2000
  ident: 32_CR23
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.18.2200
– volume: 285
  start-page: 2370
  year: 2001
  ident: 32_CR1
  publication-title: JAMA
  doi: 10.1001/jama.285.18.2370
– volume: 11
  start-page: e0155581
  year: 2016
  ident: 32_CR3
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0155581
– volume: 16
  start-page: 31
  year: 1976
  ident: 32_CR16
  publication-title: Nephron
  doi: 10.1159/000180580
– volume: 53
  start-page: 982
  year: 2009
  ident: 32_CR14
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2008.12.034
– volume: 130
  start-page: 461
  year: 1999
  ident: 32_CR36
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 351
  start-page: 1296
  year: 2004
  ident: 32_CR13
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa041031
– volume: 365
  start-page: 883
  year: 2011
  ident: 32_CR18
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1009638
– volume: 25
  start-page: 431
  year: 2014
  ident: 32_CR7
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013040361
– volume: 59
  start-page: 198
  year: 2012
  ident: 32_CR26
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.111.179713
– volume: 8
  start-page: e79717
  year: 2013
  ident: 32_CR39
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0079717
– volume: 3
  start-page: 19
  issue: Supple
  year: 2013
  ident: 32_CR15
  publication-title: Kidney Int
– volume: 365
  start-page: 981
  year: 2011
  ident: 32_CR42
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1107039
– volume: 158
  start-page: 629
  year: 2009
  ident: 32_CR41
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2009.06.031
– volume: 46
  start-page: 515
  year: 2016
  ident: 32_CR27
  publication-title: Korean Circ J
  doi: 10.4070/kcj.2016.46.4.515
– volume: 52
  start-page: 964
  year: 2012
  ident: 32_CR6
  publication-title: J Clin Pharmacol
  doi: 10.1177/0091270011409231
– volume: 361
  start-page: 1139
  year: 2009
  ident: 32_CR17
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0905561
– volume: 364
  start-page: 806
  year: 2011
  ident: 32_CR43
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1007432
– volume: 75
  start-page: 2749
  year: 2011
  ident: 32_CR31
  publication-title: Circ J
  doi: 10.1253/circj.CJ-11-1134
– volume: 30
  start-page: 776
  year: 2010
  ident: 32_CR8
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.30.8.776
– volume: 96
  start-page: 2455
  year: 1997
  ident: 32_CR2
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.7.2455
– volume: 367
  start-page: 625
  year: 2012
  ident: 32_CR5
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1105594
– volume: 374
  start-page: 525
  year: 2009
  ident: 32_CR28
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61340-4
– volume: 33
  start-page: 2821
  year: 2012
  ident: 32_CR9
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs274
– volume: 28
  start-page: 1404
  year: 2013
  ident: 32_CR35
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfs607
– volume: 75
  start-page: 2767
  year: 2011
  ident: 32_CR29
  publication-title: Circ J
  doi: 10.1253/circj.CJ-11-0780
– volume: 55
  start-page: 2319
  year: 2010
  ident: 32_CR24
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.02.029
– volume: 34
  start-page: 3572
  year: 2013
  ident: 32_CR10
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/eht328
– volume: 28
  start-page: 1396
  year: 2013
  ident: 32_CR34
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft006
– volume: 55
  start-page: 622
  year: 2010
  ident: 32_CR44
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2010.02.337
– volume: 137
  start-page: 102
  year: 2009
  ident: 32_CR20
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2008.06.029
– volume: 271
  start-page: 840
  year: 1994
  ident: 32_CR25
  publication-title: JAMA
  doi: 10.1001/jama.1994.03510350050036
– volume: 10
  start-page: e0143205
  year: 2015
  ident: 32_CR32
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0143205
– volume: 53
  start-page: 982
  year: 2009
  ident: 32_CR37
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2008.12.034
– volume: 127
  start-page: 224
  year: 2013
  ident: 32_CR11
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.107128
– volume: 119
  start-page: 1229
  year: 2017
  ident: 32_CR12
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2017.01.005
– volume: 102
  start-page: 1056
  year: 2008
  ident: 32_CR40
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2008.06.018
– volume: 42
  start-page: 1050
  year: 2003
  ident: 32_CR4
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000102971.85504.7c
– volume: 33
  start-page: 278
  year: 1985
  ident: 32_CR33
  publication-title: J Am Geriatr Soc
  doi: 10.1111/j.1532-5415.1985.tb07117.x
SSID ssj0028591
Score 2.2503114
Snippet Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 451
SubjectTerms Adult
Age
Aged
Aged, 80 and over
Atrial Fibrillation - epidemiology
Atrial Fibrillation - physiopathology
Cardiac arrhythmia
Creatinine - blood
Cross-Sectional Studies
Family medical history
Female
Gender
Glomerular Filtration Rate
Humans
Hypertension
Japan - epidemiology
Kidney - physiopathology
Male
Middle Aged
Prevalence
Risk Factors
Young Adult
Title Estimated glomerular filtration ratio is a better index than creatinine clearance (Cockcroft–Gault) for predicting the prevalence of atrial fibrillation in the general Japanese population
URI https://www.ncbi.nlm.nih.gov/pubmed/29559690
https://www.proquest.com/docview/2049881417
https://www.proquest.com/docview/2016532685
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1348-4214
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0028591
  issn: 0916-9636
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1348-4214
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0028591
  issn: 0916-9636
  databaseCode: AFBBN
  dateStart: 20050101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1348-4214
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0028591
  issn: 0916-9636
  databaseCode: 7X7
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1348-4214
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0028591
  issn: 0916-9636
  databaseCode: BENPR
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NatwwEBZtAqWXkv5vmoYp9NAWRC1bkqVTSMOmIZBQSgN7M7Ish4Wtvd2fe96hz9OX6ZNkRtZu6KE5mcWyBTufZr7RyN8w9r6lNEPVOW9aiQmK0oHbulE8lJbUZbwIgRLFi0t9diXPJ2qSNtyW6VjlxidGR930nvbIMUmX1hghRXk0_8WpaxRVV1MLjYdsVyBVIVSXk7uEi7TZotae0ByBpjdVzcJ8XspY1cyE4YjrnOt_49J_yGYMOqd77Elii3A8mPcpexC6Z-zRRaqHP2d_xrhCkXOGBq5n_c-woEOl0E5nSQwX4gWmS3BQxw93IMojAm2Yw0AYO3wTeOoeQQCADyfoIaN3_nvz-6tbz1YfAYktzBc0Kx2SxocD_USMkluAvgUXm3_gxPWCuhjFqaddHHg96FrDOUZl6nYJ823LsBfs6nT84-SMp4YM3BfSrrizKkdG45uyyK10TRZE8HWJFMA7bTAaYmjLnDQKaUVhMffKvSoxTa0LQd_zuuIl2-n6LrxmQLYJZWu1qgspna8z6Vwjg0E66kTrRyzbmKPySa2cmmbMqlg1L0w1WLBCC5K-aV7pEfu0fWQ-SHXcN_hgY-MqrdpldYexEXu3vY3rjYoo-B_1axojtELOa9SIvRqwsZ0tJzk_bbP9-1_-hj3OI_BoL-eA7awW6_AWqc2qPoz4PWS7X8aX377fAsii-YA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLVKkYAN4s1AgYsEEiBZJI7tJAuEUGmZPqarVppdsB2nGmmaTOchxI5_4D_4A36GL-FeJ5mKBd11FUXxQ8q9vg9f-xzGXlWUZigreFlJTFCU9jy3peI-zQldxsXeU6I4OtLDE7k_VuMN9qu_C0PHKnubGAx12TjaI8ckXeZZFss4_Tg758QaRdXVnkKjVYsD__0bpmyLD3ufUb6vhdjdOd4e8o5VgLtE5ktuciXQLbsyTUQuTRn52Duboh9zRmdo0tE-R0ZmCn1jkmMCIZxKMdeySUyXUk2C415j12USScLqT8cXCR5hwQVsv1hzVGzdV1GT7P1ChipqFGcc15Hg-l8_-J_gNji53TvsdhedwqdWne6yDV_fYzdGXf39Pvu9gxYBY1xfwum0OfNzOsQK1WTage9CeMBkAQZsuCgEAY4RaIMe2gC1xpHAEVsFKRy82UaLHLzBnx8_v5jVdPkWMJCG2ZxmpUPZ2NnTK64JMkPQVGAC2QhObOfEmhSmntSh4WmLow37GAUQuybM1hRlD9jJlYjqIdusm9o_ZkCy8WmVa2UTKY2zkTSmlD7D8NfElRuwqBdH4Tp0dCLpmBahSp9kRSvBAiVIeKqi0AP2bt1l1kKDXNZ4q5dx0VmJRXGh0wP2cv0Z1zcVbfAfNStqE2uFMXamBuxRqxvr2QTBB-o8enL54C_YzeHx6LA43Ds6eMpuiaCEtI-0xTaX85V_hmHV0j4Pugzs61Uvnr8IyzEx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9VAFB5qheJGfPfWqkdQUGFoMq8kCxFpe-3DFhcW7i5OJpNy4Zrc3gfizv_gvxH8M_4Sz5kkt7iwu65CyDwg5z3nzHcYe1FRmKELwctKYYCijedZUWruk4zQZVzsPQWKJ6fm4EwdjfRojf3q78JQWWWvE4OiLhtHZ-QYpKssTWMVJztVVxbxaW_4bnrBqYMUZVr7dhotixz7798wfJu_PdxDWr8UYrj_efeAdx0GuJMqW3CbaYEm2pWJFJmyZeRj74oEbZqzJkX1jro6sirVaCdlhsGEcDrBuKuQMV1QtRLXvcFuJlJJKidLRpfBHuHCBZy_2HBkctNnVGW6M1choxrFKUeZEtz8axP_4-gGgze8w253niq8b1nrLlvz9T22cdLl4u-z3_uoHdDf9SWcT5qvfkYFrVCNJx0QL4QHjOdgoQiXhiBAMwId1kPrrNa4EjjqXEHMB692UTsHy_Dnx88PdjlZvAZ0qmE6o12pQBsne3pF-SCVBE0FNjQewY2LGXVQCluP6zDwvMXUhiP0CKjTJkxX7coesLNrIdVDtl43td9kQLTxSZUZXUilrCsiZW2pfIqusI0rN2BRT47cdUjp1LBjkoeMvUzzloI5UpCwVUVuBuzNasq0hQm5avB2T-O80xjz_JK_B-z56jPKOiVw8B81SxoTG43-dqoH7FHLG6vdBEEJmizaunrxZ2wDxSb_eHh6_JjdEoEH6Uhpm60vZkv_BD2sRfE0sDKwL9ctO38BX3E1bA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimated+glomerular+filtration+ratio+is+a+better+index+than+creatinine+clearance+%28Cockcroft-Gault%29+for+predicting+the+prevalence+of+atrial+fibrillation+in+the+general+Japanese+population&rft.jtitle=Hypertension+research&rft.au=Yonezawa%2C+Yutaka&rft.au=Horinaka%2C+Shigeo&rft.au=Shirakawa%2C+Chiaki&rft.au=Kogure%2C+Yoshio&rft.date=2018-06-01&rft.eissn=1348-4214&rft.volume=41&rft.issue=6&rft.spage=451&rft_id=info:doi/10.1038%2Fs41440-018-0032-6&rft_id=info%3Apmid%2F29559690&rft.externalDocID=29559690
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon